Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis.
about
Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not goldRadionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerAn exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to boneCancer-targeted therapies and radiopharmaceuticalsWhole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis.(223)Ra and other bone-targeting radiopharmaceuticals-the translation of radiation biology into clinical practice.Developing models for cachexia and their implications in drug discovery.Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.Radium-223 dichloride therapy in breast cancer with osseous metastases.Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model.Radionuclides in oncology clinical practice - review of the literature.Bone-Targeted Therapies in Cancer-Induced Bone Disease.Targeted α Therapies for the Treatment of Bone Metastases.The Biology of Bone Metastasis.Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models.Ra223 in Bone Metastases with Osteolytic Activity.Recent Advances in Prostate Cancer Treatment and Drug Discovery.Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis
P2860
Q28066293-520CA42F-EB77-4047-B969-1B3884BB444DQ28079918-E9FFB68F-B81E-40F9-8CC0-B56208C6E51AQ33608134-2A955464-A9A4-405E-8153-51AAC7E2A3E8Q34212446-A5C7C25D-C59C-49AC-9B14-27D51E6B2444Q35683440-7125736A-287C-4533-99D4-A93411BE7E71Q36849160-F60EF76C-F06C-45AA-90AE-030BA4DB3907Q38391693-CADD94C5-9FCD-402A-A7BD-3641DFEE0461Q38451282-784CBAD8-A066-45B8-92BA-2E389E0D45AAQ38581768-3230BEA8-B723-4770-AC21-65F3A6926FFEQ38995718-A3093D01-DD0B-421A-A4AC-5D8B43882C4CQ39180590-18BF47AB-CD15-46E6-BBAA-0F4910513B95Q47557128-7C8B3339-544F-40B0-B2C5-9F370400AE13Q47916271-8CAB2AF3-026A-4D9C-8E32-4FBDB89C0372Q48110513-680505A2-6680-4FE6-9D81-FC595C46CE9BQ49271846-FE73FE2C-C2E5-4418-98D9-E53331BF54C1Q50175870-F5154280-B779-4762-98D9-8973303653E5Q52778839-C2652C8F-2C8C-4008-95F7-A928B41DF69DQ53826785-3B579BAE-6452-4BC0-AD29-252899DCFBE1Q54111821-EB66D36C-E051-4035-8771-403F92A42AC4Q57493778-41F84E08-EE47-41E3-B6D9-2F485070DAA6
P2860
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Survival benefit with radium-2 ...... breast cancer bone metastasis.
@en
Survival benefit with radium-2 ...... breast cancer bone metastasis.
@nl
type
label
Survival benefit with radium-2 ...... breast cancer bone metastasis.
@en
Survival benefit with radium-2 ...... breast cancer bone metastasis.
@nl
prefLabel
Survival benefit with radium-2 ...... breast cancer bone metastasis.
@en
Survival benefit with radium-2 ...... breast cancer bone metastasis.
@nl
P2093
P356
P1476
Survival benefit with radium-2 ...... breast cancer bone metastasis.
@en
P2093
Arne Scholz
Dominik Mumberg
Esa Alhoniemi
Jukka P Rissanen
Jussi M Halleen
Karl Ziegelbauer
Katja M Fagerlund
Mari I Suominen
Rami Käkönen
Sanna-Maria Käkönen
P304
P356
10.1093/JNCI/DJT116
P407
P577
2013-05-16T00:00:00Z